Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21
Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21| GALECTIN (NASDAQ: GALT) | Delayed: 2.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $3.05 | |||
| Open | $2.80 | 52 Week Low | $0.49 | |||
| Day High | $2.80 | P/E | N/A | |||
| Day Low | $2.80 | EPS | $-1.32 | |||
| Volume | 4 | |||||

